Research into bleeding prevention post-birth could save lives

December 18, 2012 in Obstetrics & gynaecology

Research brings together evidence about the potential for misoprostol to prevent bleeding after home births in low resource countries.

A new research review published today (27 November) in BJOG: An International Journal of demonstrates that taking the tablet misoprostol after the birth of the baby helps prevent postpartum (PPH) (a of more than 500ml) amongst women delivering at home. The evidence for this is strongest in two studies in India and Pakistan, where frontline attended the delivery and provided the tablets.

Every day about 800 women die from complications associated with pregnancy and childbirth. The majority of these deaths occur in low resource countries and many are the result of bleeding following the birth of the baby.

Previously published reviews have examined medications to prevent PPH, but this is the first to focus on misoprostol taken orally (as a tablet) in a setting. "We know that another medication, , is the most effective means of preventing PPH. However, it requires cold storage and needs to be given by a skilled . The reality is that many women in low resource countries give birth in settings that offer neither of these things. For these women having access to a simple that reduces their chance of bleeding heavily after their baby is born could be lifesaving." said lead researcher Professor Vanora Hundley of Bournemouth University.

Dr Bilal Avan, Scientific Coordinator for IDEAS, an evaluation project at the London School of Hygiene & Tropical Medicine working with partners in areas where maternal and newborn mortality burdens are high, said:

"Given the poor health system infrastructure and lack of skilled staff in low resource settings, there is significant potential for the innovative use of technologies or drugs, like misoprostol, for safe home deliveries. Although by no means a substitute for giving birth in a health facility, using misoprostol at a home delivery could be an effective intermediate measure until health systems in these settings achieve acceptable standards of service delivery."

The authors from Bournemouth University, London School of Hygiene & Tropical Medicine, University of Aberdeen and INOVA Fairfax, analysed data from six trials involving a total of 10,798 women who gave birth at home in low and middle income countries. Although all six trials showed some benefits from the use of misoprostol, only two – both in South Asia ‐ provided sufficiently‐robust evidence to draw firm conclusions, and thus further trials are needed in other types of home birth settings.

There are also concerns about potential adverse effects. The review shows that self‐limiting effects such as shivering and fever were more common among the group of women that took misoprostol. However, in all studies there was limited data on adverse effects for the baby or the potential for inappropriate or inadvertent use of the tablets.

As emphasized by Professor Wendy Graham from the University of Aberdeen "Deciding when evidence of a medication is strong enough and sufficiently generalizable to recommend wide‐scale adoption is often difficult, particularly where health systems are weak, and where the drug also carries some risks. From our review, we highlight the need to continue to build the evidence base to inform routine use of across the very diverse circumstances in which homes birth take place, and to develop local implementation and safety guidelines.

More information: Hundley, V. et al., Should oral misoprostol be used to prevent postpartum haemorrhage in home-birth settings in low-resource countries? A systematic review of the evidence, BJOG: An International Journal of Obstetrics & Gynaecology, 27 NOV 2012, DOI: 10.1111/1471-0528.12049.

Journal reference: BJOG: An International Journal of Obstetrics and Gynaecology search and more info website

Provided by Bournemouth University

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

Bulletin provides guidelines for second-trimester abortion

(HealthDay)—New evidence-based guidelines provide guidance on medical and surgical methods for second-trimester abortion and management of associated complications, according to a practice bulletin published ...

Obstetrics & gynaecology created May 24, 2013 | popularity not rated yet | comments 1

ACOG: Hormone therapy not recommended to prevent CHD

(HealthDay)—Menopausal hormone therapy should not be used for prevention of coronary heart disease, according to a Committee Opinion from the American College of Obstetricians and Gynecologists (ACOG) published ...

Obstetrics & gynaecology created May 24, 2013 | popularity not rated yet | comments 0

Iodine deficiency during pregnancy may adversely affect children's mental development

A study of around 1,000 UK mothers and their children, published in The Lancet, has revealed that iodine deficiency in pregnancy may have an adverse effect on children's mental development. The research raises concerns that t ...

Obstetrics & gynaecology created May 21, 2013 | popularity not rated yet | comments 0

72 percent of pregnant women experience constipation and other bowel problems

Nearly three out of four pregnant women experience constipation, diarrhea or other bowel disorders during their pregnancies, a Loyola University Medical Center study has found.

Obstetrics & gynaecology created May 20, 2013 | popularity not rated yet | comments 0

Women's reproductive ability may be related to immune system status

New research indicates that women's reproductive function may be tied to their immune status. Previous studies have found this association in human males, but not females.

Obstetrics & gynaecology created May 17, 2013 | popularity not rated yet | comments 0 | with audio podcast


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.